118 related articles for article (PubMed ID: 21489305)
1. Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors.
Miller CA; Settle SH; Sulman EP; Aldape KD; Milosavljevic A
BMC Med Genomics; 2011 Apr; 4():34. PubMed ID: 21489305
[TBL] [Abstract][Full Text] [Related]
2. Identifying overlapping mutated driver pathways by constructing gene networks in cancer.
Wu H; Gao L; Li F; Song F; Yang X; Kasabov N
BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S3. PubMed ID: 25859819
[TBL] [Abstract][Full Text] [Related]
3. Using MEMo to discover mutual exclusivity modules in cancer.
Ciriello G; Cerami E; Aksoy BA; Sander C; Schultz N
Curr Protoc Bioinformatics; 2013 Mar; Chapter 8():8.17.1-8.17.12. PubMed ID: 23504936
[TBL] [Abstract][Full Text] [Related]
4. A large scale survey reveals that chromosomal copy-number alterations significantly affect gene modules involved in cancer initiation and progression.
Alloza E; Al-Shahrour F; Cigudosa JC; Dopazo J
BMC Med Genomics; 2011 May; 4():37. PubMed ID: 21548942
[TBL] [Abstract][Full Text] [Related]
5. Systematic assessment of prognostic molecular features across cancers.
Santhanam B; Oikonomou P; Tavazoie S
Cell Genom; 2023 Mar; 3(3):100262. PubMed ID: 36950380
[TBL] [Abstract][Full Text] [Related]
6. Mutual exclusivity analysis identifies oncogenic network modules.
Ciriello G; Cerami E; Sander C; Schultz N
Genome Res; 2012 Feb; 22(2):398-406. PubMed ID: 21908773
[TBL] [Abstract][Full Text] [Related]
7. De novo discovery of mutated driver pathways in cancer.
Vandin F; Upfal E; Raphael BJ
Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
[TBL] [Abstract][Full Text] [Related]
8. TMBserval: a statistical explainable learning model reveals weighted tumor mutation burden better categorizing therapeutic benefits.
Wang Y; Wang J; Fang W; Xiao X; Wang Q; Zhao J; Liu J; Yang S; Liu Y; Lai X; Song X
Front Immunol; 2023; 14():1151755. PubMed ID: 37234148
[TBL] [Abstract][Full Text] [Related]
9. SuperDendrix algorithm integrates genetic dependencies and genomic alterations across pathways and cancer types.
Park TY; Leiserson MDM; Klau GW; Raphael BJ
Cell Genom; 2022 Feb; 2(2):. PubMed ID: 35382456
[TBL] [Abstract][Full Text] [Related]
10. Temporal and sequential order of nonoverlapping gene networks unraveled in mated female Drosophila.
Pasquier C; Robichon A
Life Sci Alliance; 2022 Feb; 5(2):. PubMed ID: 34844981
[TBL] [Abstract][Full Text] [Related]
11. Identification of Common Driver Gene Modules and Associations between Cancers through Integrated Network Analysis.
Gao B; Zhao Y; Gao Y; Li G; Wu LY
Glob Chall; 2021 Sep; 5(9):2100006. PubMed ID: 34504716
[TBL] [Abstract][Full Text] [Related]
12. Integrating Protein-Protein Interaction Networks and Somatic Mutation Data to Detect Driver Modules in Pan-Cancer.
Wu H; Chen Z; Wu Y; Zhang H; Liu Q
Interdiscip Sci; 2022 Mar; 14(1):151-167. PubMed ID: 34491536
[TBL] [Abstract][Full Text] [Related]
13. Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response.
Pinoli P; Srihari S; Wong L; Ceri S
BMC Bioinformatics; 2021 May; 22(1):250. PubMed ID: 33992077
[TBL] [Abstract][Full Text] [Related]
14. Identifying modules of cooperating cancer drivers.
Klein MI; Cannataro VL; Townsend JP; Newman S; Stern DF; Zhao H
Mol Syst Biol; 2021 Mar; 17(3):e9810. PubMed ID: 33769711
[TBL] [Abstract][Full Text] [Related]
15. Ranking cancer drivers via betweenness-based outlier detection and random walks.
Erten C; Houdjedj A; Kazan H
BMC Bioinformatics; 2021 Feb; 22(1):62. PubMed ID: 33568049
[TBL] [Abstract][Full Text] [Related]
16. DriveWays: a method for identifying possibly overlapping driver pathways in cancer.
Baali I; Erten C; Kazan H
Sci Rep; 2020 Dec; 10(1):21971. PubMed ID: 33319839
[TBL] [Abstract][Full Text] [Related]
17. A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities.
Narayan RS; Molenaar P; Teng J; Cornelissen FMG; Roelofs I; Menezes R; Dik R; Lagerweij T; Broersma Y; Petersen N; Marin Soto JA; Brands E; van Kuiken P; Lecca MC; Lenos KJ; In 't Veld SGJG; van Wieringen W; Lang FF; Sulman E; Verhaak R; Baumert BG; Stalpers LJA; Vermeulen L; Watts C; Bailey D; Slotman BJ; Versteeg R; Noske D; Sminia P; Tannous BA; Wurdinger T; Koster J; Westerman BA
Nat Commun; 2020 Jun; 11(1):2935. PubMed ID: 32523045
[TBL] [Abstract][Full Text] [Related]
18. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
Bokhari Y; Alhareeri A; Arodz T
BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
[TBL] [Abstract][Full Text] [Related]
19. Uncovering the subtype-specific temporal order of cancer pathway dysregulation.
Khakabimamaghani S; Ding D; Snow O; Ester M
PLoS Comput Biol; 2019 Nov; 15(11):e1007451. PubMed ID: 31710622
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
